June 28 (Reuters) - Advicenne SA ALDVI.PA :
* ADVICENNE ANNOUNCES COMMERCIALIZATION AGREEMENT WITH TAÏBA
HEALTHCARE FOR SIBNAYAL IN MIDDLE-EAST
* ADVICENNE WILL RECEIVE A TRANSFER PRICE AND ROYALTIES FOR
AN
AMOUNT MARKEDLY HIGHER THAN 50% OF FUTURE SALES OF SIBNAYAL
* UNDER TERMS OF AGREEMENT, TAIBA HAS EXCLUSIVE MARKETING
RIGHTS
TO SIBNAYAL IN ITS INDICATION OF TERRITORIES DEFINED IN CONTRACT
* ADVICENNE WILL RECEIVE PROCEEDS FROM SALE OF SIBNAYAL IN
FORM OF
A TRANSFER PRICE AND ROYALTIES FOR A COMBINED AMOUNT
SIGNIFICANTLY GREATER THAN 50% OF FUTURE SALES
Source text for Eikon: ID:nBw5QhMk0a
Further company coverage: ALDVI.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))